 |
 |
 |
 |
 |
|
|
Fenretinide
| Fenretinide |
|
| IUPAC name |
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-
dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)
nona-2,4,6,8-tetraenamide |
| Identifiers |
| CAS number |
65646-68-6 |
| PubChem |
5288209 |
| MeSH |
Fenretinide |
| Properties |
| Molecular formula |
C26H33NO2 |
| Molar mass |
391.546 g/mol |
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references |
Fenretinide (INN) is a retinoid which has been investigated for potential use in the treatment of cancer.[1]
References
- ^ Wu J, DiPietrantonio A, Hsieh T (2001). "Mechanism of fenretinide (4-HPR)-induced cell death". Apoptosis 6 (5): 377-88. PMID 11483862.
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fenretinide". A list of authors is available in Wikipedia.
|
|
|
|
|
|